|
I'm not even sure if you even read that list, given that it has tons of medicines that were discovered by researchers working for Roche, Sanofi, Chugai, and GlaxoSmithKline. And the information on the pharmaceuticals involved fails to mention the feeder research that comes from universities in Cambridge, Zurich, London, Tokyo, etc. Most of this had gigantic participation of state research institutions, and if you look at the American pharma companies, almost all are based and house most of their research efforts in the state of New York and New Jersey, Massachussets, and the Bay Area, to the exclusion of pretty much everywhere else. That makes for a great case of the utility of the well-funded research universities in forming staff for pharma, but it's not exactly a proof that any particular model of funding for pharma works better than others. It's also interesting to note that most of these pharmaceuticals target and _incredibly small_ number of people worldwide at outrageous costs. Not to take merit away from the huge research efforts, but honestly it just shows where profit-driven research efforts go instead of rational, nation-wide public health initiatives that are objectively far better at increasing quality of life for entire populations. |
Yes, at their US research labs. Most of these companies do a lot of their research in the US these days and continue to move more R&D to the US. If it's developed in the US by individuals working in the US because the opportunities are in the US, that makes it a US-developed drug. I went through each and every WHO essential medicines drug developed since 2000 and verified where each was developed.
> It's also interesting to note that most of these pharmaceuticals target and _incredibly small_ number of people worldwide at outrageous costs.
As someone that uses an orphan drug developed in the US to improve my quality of life, I'm glad. Do you want to take that option away from me and others like me?